Civic Intelligence

Androgen Excess Society

EIN 54-2080264 • 501(c)3 • Bellflower, CA

Profile

To organize an annual meeting reviewing current bevelopments and future avenues of investigation regarding androgen excess related disorders. Advance our education and understanding of the molecular, genetic and pathophysiolgic mechanisms underlying androgen excess.

9908 Beverly StreetBellflower, CA 90706

www.ae-society.org

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

Score unavailable

No value available

Liabilities-to-assets requires both liabilities and assets on the latest valid filing.

Source year 2025

Liabilities / Revenue

Score unavailable

No value available

Liabilities-to-revenue requires both liabilities and revenue on the latest valid filing.

Source year 2025

Net Margin

78th percentile

25%

Higher net margin than 78% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2025

Top Officer Pay

86th percentile

$15,000

Higher top officer pay than 86% of similar nonprofits.

Top officer pay equals 9.7% of source-year revenue.

501(c)3 • <$500k nonprofits • Source year 2025

Asset Growth

77th percentile

22%

Faster asset growth than 77% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2024 to 2025

Revenue Growth

33rd percentile

-21%

Faster revenue growth than 33% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2024 to 2025

Assets

Up

$213,818

Up $39,048 (+22%) from 2024

Liabilities

-

No earlier filing loaded for comparison.

Net Assets

Up

$213,818

Up $39,048 (+22%) from 2024

Revenue

Down

$154,772

Down $40,728 (-21%) from 2024

Expenses

Down

$115,724

Down $99,255 (-46%) from 2024

Net Income

Up

$39,048

Up $58,527 (+300%) from 2024

Trend Graphs

Balance Sheet Trend

Grouped bars show assets, liabilities, and net assets across loaded filings.

$300K$200K$100K$0Assets 2012: $96,072Liabilities 2012: $02012Assets 2013: $102,132Liabilities 2013: $02013Assets 2014: $83,430Net Assets 2014: $83,4302014Assets 2015: $83,430Liabilities 2015: $02015Assets 2016: $70,222Net Assets 2016: $70,2222016Assets 2017: $94,272Net Assets 2017: $94,2722017Assets 2018: $111,648Net Assets 2018: $111,6482018Assets 2019: $125,932Net Assets 2019: $125,9322019Assets 2020: $122,184Net Assets 2020: $122,1842020Assets 2021: $139,055Liabilities 2021: $02021Assets 2022: $168,272Liabilities 2022: $0Net Assets 2022: $168,2722022Assets 2023: $194,249Liabilities 2023: $0Net Assets 2023: $194,2492023Assets 2024: $174,770Liabilities 2024: $0Net Assets 2024: $174,7702024Assets 2025: $213,818Net Assets 2025: $213,8182025

Highlighted filing

2025

Assets$213,818
Liabilities-
Net Assets$213,818

Operations Trend

Revenue, expenses, and net income by year, with the latest filing highlighted.

$300K$200K$100K$0-$100KRevenue 2012: $64,721Expenses 2012: $69,711Net Income 2012: -$4,9902012Revenue 2013: $40,292Expenses 2013: $34,232Net Income 2013: $6,0602013Revenue 2014: $56,667Expenses 2014: $70,096Net Income 2014: -$13,4292014Revenue 2015: $56,667Expenses 2015: $70,096Net Income 2015: -$13,4292015Revenue 2016: $69,155Expenses 2016: $82,363Net Income 2016: -$13,2082016Revenue 2017: $68,649Expenses 2017: $44,599Net Income 2017: $24,0502017Revenue 2018: $71,696Expenses 2018: $54,320Net Income 2018: $17,3762018Revenue 2019: $74,817Expenses 2019: $60,533Net Income 2019: $14,2842019Revenue 2020: $62,335Expenses 2020: $66,083Net Income 2020: -$3,7482020Revenue 2021: $30,522Expenses 2021: $13,651Net Income 2021: $16,8712021Revenue 2022: $76,185Expenses 2022: $46,968Net Income 2022: $29,2172022Revenue 2023: $160,550Expenses 2023: $134,573Net Income 2023: $25,9772023Revenue 2024: $195,500Expenses 2024: $214,979Net Income 2024: -$19,4792024Revenue 2025: $154,772Expenses 2025: $115,724Net Income 2025: $39,0482025

Highlighted filing

2025

Revenue$154,772
Expenses$115,724
Net Income$39,048

Filings

Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2025Detailed filing. Detailed filing data is available for this year.$2.14$2.14$1.55$1.16$0.39
2024XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$1.75$0.00$1.75$1.96$2.15$0.19
2023XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$1.94$0.00$1.94$1.61$1.35$0.26
2022Detailed filing. Detailed filing data is available for this year.$1.68$0.00$1.68$0.76$0.47$0.29
2021Summary only. Only limited summary data is available for this year.$1.39$0.00$0.31$0.14$0.17
2020Detailed filing. Detailed filing data is available for this year.$1.22$1.22$0.62$0.66$0.04
2019Detailed filing. Detailed filing data is available for this year.$1.26$1.26$0.75$0.61$0.14
2018Detailed filing. Detailed filing data is available for this year.$1.12$1.12$0.72$0.54$0.17
2017Detailed filing. Detailed filing data is available for this year.$0.94$0.94$0.69$0.45$0.24
2016Detailed filing. Detailed filing data is available for this year.$0.70$0.70$0.69$0.82$0.13
2015Summary only. Only limited summary data is available for this year.$0.83$0.00$0.57$0.70$0.13
2014Detailed filing. Detailed filing data is available for this year.$0.83$0.83$0.57$0.70$0.13
2013Summary only. Only limited summary data is available for this year.$1.02$0.00$0.40$0.34$0.06
2012Summary only. Only limited summary data is available for this year.$0.96$0.00$0.65$0.70$0.05
Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jul 1, 2024 to Jun 30, 2025
Signed
Jan 9, 2026
Return Version
2024v5.0
Gross Receipts
$154,772
Mission and Program Overview

Mission

To organize an annual meeting reviewing current developments and future avenue of investigation regarding androgen excess related disorders. Advance our education and understanding of the molecular, genetic and pathophysiologic mechanisms underlying androgen excess.

Program Services

DescriptionGrantsExpenses
TO ORGANIZE AN ANNUAL MEETING REVIEWING CURRENT DEVELOPMENTS AND FUTURE AVENUE OF INVESTIGATION REGARDING ANDROGEN EXCESS RELATED DISORDERS. ADVANCE OUR EDUCATION AND UNDERSTANDING OF THE MOLECULAR, GENETIC AND PATHOPHYSIOLOGIC MECHANISMS UNDERLYING ANDROGEN EXCESS.-$115,724
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
JAMES MORROWManaging Director-$15,000-$15,000
ANUJA DOKRAS MD PHDExecutive Di-$10,000-$10,000
JOOP LAVEN MD PHDPast Preside-$0--
TANIA BURGERT MDSecretary/Tr-$0--
TERHI PILTONEN MD PHDPresident-$0--
Filing and Contact Details

Filer

Filer Name
Androgen Excess Society
EIN
54-2080264
Phone
3109905502
Address
9908 BEVERLY STREET, BELLFLOWER, CA 90706

Signing Officer

Name
James Morrow
Title
Managing Director
Phone
3109905502
Signed
2026-01-09

Preparer

Firm
Conrad Burnett Norris & Gordon LLC
Address
1800 PROVIDENCE PARK STE 100, BIRMINGHAM, AL 35242-5043
Preparer
John S Gordon
Phone
2059805999
Supplemental Narrative

Additional Explanations

Form 990-ez, Part I, Line 16

Expenses 3,244 85,674 total 88,918

Form 990-ez, Part III

To organize an annual meeting reviewing current developments and future avenue of investigation regarding androgen excess related disorders. Advance our education and understanding of the molecular, genetic and pathophysiologic mechanisms underlying androgen excess.

Form 990-ez, Part III, Line 28

To organize an annual meeting reviewing current developments and future avenue of investigation regarding androgen excess related disorders. Advance our education and understanding of the molecular, genetic and pathophysiologic mechanisms underlying androgen excess.

Raw XML Appendix158 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/AddressChangeInd0X
IRS990EZ/BooksInCareOfDetail/PersonNm0JAMES MORROW
IRS990EZ/BooksInCareOfDetail/PhoneNum03109905502
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt09908 BEVERLY STREET
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0BELLFLOWER
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd090706
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt0174770
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt0213818
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/ContributionsGiftsGrantsEtcAmt050825
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt039048
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt01806
IRS990EZ/FiledScheduleAInd0true
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt0174770
IRS990EZ/Form990TotalAssetsGrp/EOYAmt0213818
IRS990EZ/GrossReceiptsAmt0154772
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InvestmentIncomeAmt0586
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0false
IRS990EZ/MembershipDuesAmt0103361
IRS990EZ/MethodOfAccountingCashInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt0174770
IRS990EZ/NetAssetsOrFundBalancesEOYAmt0213818
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt0174770
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt0213818
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt02.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt12.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt22.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt32.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt42.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt215000
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt410000
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0JOOP LAVEN MD PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1TANIA BURGERT MD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2JAMES MORROW
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3TERHI PILTONEN MD PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4ANUJA DOKRAS MD PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0PAST PRESIDE
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1SECRETARY/TR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2MANAGING DIR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3PRESIDENT
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4EXECUTIVE DI
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherExpensesTotalAmt088918
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0TO ORGANIZE AN ANNUAL MEETING REVIEWING CURRENT DEVELOPMENTS AND FUTURE AVENUE OF INVESTIGATION REGARDING ANDROGEN EXCESS RELATED DISORDERS. ADVANCE OUR EDUCATION AND UNDERSTANDING OF THE MOLECULAR, GENETIC AND PATHOPHYSIOLOGIC MECHANISMS UNDERLYING ANDROGEN EXCESS.
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0TO ORGANIZE AN ANNUAL MEETING REVIEWING CURRENT DEVELOPMENTS AND FUTURE AVENUE OF INVESTIGATION REGARDING ANDROGEN EXCESS RELATED DISORDERS. ADVANCE OUR EDUCATION AND UNDERSTANDING OF THE MOLECULAR, GENETIC AND PATHOPHYSIOLOGIC MECHANISMS UNDERLYING ANDROGEN EXCESS.
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt0115724
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/SalariesOtherCompEmplBnftAmt025000
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TotalExpensesAmt0115724
IRS990EZ/TotalProgramServiceExpensesAmt0115724
IRS990EZ/TotalRevenueAmt0154772
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0N/A
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt050825
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt084170
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt096324
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt040403
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus4YearsAmt013036
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt0284758
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearAmt0586
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus1YearAmt08422
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus2YearsAmt049902
IRS990ScheduleA/GrossInvestmentIncome509Grp/TotalAmt058910
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearAmt0103947
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus1YearAmt0107248
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus2YearsAmt053169
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus3YearsAmt035782
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus4YearsAmt017486
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt0317632
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearAmt0586
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus1YearAmt08422
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus2YearsAmt049902
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/TotalAmt058910
IRS990ScheduleA/InvestmentIncomeCYPct00.09000
IRS990ScheduleA/InvestmentIncomePYPct00.00000
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct00.91090
IRS990ScheduleA/PublicSupportTotal509Amt0602390
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt0154772
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt0191418
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt0149493
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt076185
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt030522
IRS990ScheduleA/Total509Grp/TotalAmt0602390
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt0155358
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt0199840
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt0199395
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt076185
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt030522
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt0661300
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0EXPENSES 3,244 85,674 TOTAL 88,918
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1TO ORGANIZE AN ANNUAL MEETING REVIEWING CURRENT DEVELOPMENTS AND FUTURE AVENUE OF INVESTIGATION REGARDING ANDROGEN EXCESS RELATED DISORDERS. ADVANCE OUR EDUCATION AND UNDERSTANDING OF THE MOLECULAR, GENETIC AND PATHOPHYSIOLOGIC MECHANISMS UNDERLYING ANDROGEN EXCESS.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2TO ORGANIZE AN ANNUAL MEETING REVIEWING CURRENT DEVELOPMENTS AND FUTURE AVENUE OF INVESTIGATION REGARDING ANDROGEN EXCESS RELATED DISORDERS. ADVANCE OUR EDUCATION AND UNDERSTANDING OF THE MOLECULAR, GENETIC AND PATHOPHYSIOLOGIC MECHANISMS UNDERLYING ANDROGEN EXCESS.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990-EZ, PART I, LINE 16
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990-EZ, PART III
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990-EZ, PART III, LINE 28
ReturnHeader/BuildTS02025-03-06 01:10:19Z
ReturnHeader/BusinessOfficerGrp/PersonNm0JAMES MORROW
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0MANAGING DIRECTOR
ReturnHeader/BusinessOfficerGrp/PhoneNum03109905502
ReturnHeader/BusinessOfficerGrp/SignatureDt02026-01-09
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0ANDROGEN EXCESS SOCIETY
ReturnHeader/Filer/BusinessNameControlTxt0ANDR
ReturnHeader/Filer/EIN0542080264
ReturnHeader/Filer/PhoneNum03109905502
ReturnHeader/Filer/USAddress/AddressLine1Txt09908 BEVERLY STREET
ReturnHeader/Filer/USAddress/CityNm0BELLFLOWER
ReturnHeader/Filer/USAddress/StateAbbreviationCd0CA
ReturnHeader/Filer/USAddress/ZIPCd090706
ReturnHeader/IRSResponsiblePrtyInfoCurrInd0true
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0263970316
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0CONRAD BURNETT NORRIS & GORDON LLC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt01800 PROVIDENCE PARK STE 100
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0BIRMINGHAM
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0AL
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd0352425043
ReturnHeader/PreparerPersonGrp/PhoneNum02059805999
ReturnHeader/PreparerPersonGrp/PreparationDt02026-01-09
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0JOHN S GORDON
ReturnHeader/ReturnTs02026-01-20T11:33:53-05:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02024-07-01
ReturnHeader/TaxPeriodEndDt02025-06-30
ReturnHeader/TaxYr02024

Document Assets

No mirrored PDF or thumbnail assets are attached yet.